Acadian Asset Management’s RxSight RXST Stock Holding History

Acadian Asset Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.22M	Buy	1,501,180 +482,053	+47%	+$2.91M	0.01%	692
2026 Q1	$6.27M	Buy	1,019,127 +602,299	+144%	+$5M	0.01%	648
2025 Q4	$4.34M	Buy	416,828 +137,902	+49%	+$1.38M	0.01%	692
2025 Q3	$2.5M	Buy	278,926 +277,695	+22,558%	+$2.44M	﹤0.01%	840
2025 Q2	$16K	Buy	+1,231	New	+$18.5K	﹤0.01%	1596
2024 Q3	–	Sell	-2,441	Closed	-$146K	–	2306
2024 Q2	$146K	Sell	2,441 -9,920	-80%	-$567K	﹤0.01%	1486
2024 Q1	$637K	Sell	12,361 -21,672	-64%	-$1.06M	﹤0.01%	951
2023 Q4	$1.37M	Sell	34,033 -129,628	-79%	-$3.8M	0.01%	769
2023 Q3	$4.56M	Sell	163,661 -3,281	-2%	-$97.8K	0.02%	462
2023 Q2	$4.81M	Buy	166,942 +152,702	+1,072%	+$3.4M	0.02%	470
2023 Q1	$236K	Buy	+14,240	New	+$201K	﹤0.01%	1228
2022 Q4	–	Sell	-1,611	Closed	-$19K	–	1897
2022 Q3	$19K	Buy	+1,611	New	+$22.1K	﹤0.01%	1607

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 37.48% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Acadian Asset Management's RXST Position: Q2 2026 in Review

Acadian Asset Management increased its RxSight (RXST) stake by 47% in Q2 2026, buying an estimated $2.91M and bringing the position to 1,501,180 shares worth $7.22M. The position accounts for 0.01% of the portfolio, ranked #692.

Acadian Asset Management first reported a position in RXST in Q3 2022 and has held it in 12 quarters since. 137 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Acadian Asset Management held 1,501,180 shares of RxSight worth $7.22M as of Q2 2026.
Acadian Asset Management bought 482,053 RxSight shares in Q2 2026, an estimated $2.91M.
RxSight made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #692 holding.
Acadian Asset Management first reported a position in RxSight in Q3 2022 and has held it in 12 quarters since.
137 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.